NUR 603 Pharm Practice questions with
correct answers
Botulinum toxin blocks the release of acetylcholine from cholinergic nerve
| | | | | | | | | |
terminals. Which is a possible effect of botulinum toxin?
| | | | | | | |
A. Skeletal Muscle paralysis
| | |
B. Improvement of myasthenia gravis symptoms
| | | | |
C. Increased salivation
| |
D. Reduced heart rate - CORRECT ANSWER✔✔-A. Acetylcholine released by
| | | | | | | | | |
cholinergic neurons acts on nicotinic receptors in the skeletal muscle cells to
| | | | | | | | | | | |
cause contraction. Therefore, blockade of ACh release causes skeletal muscle
| | | | | | | | | |
paralysis. Myasthenia gravis is an autoimmune diseases where antibodies are
| | | | | | | | | |
produced against nicotinic receptors. A reduction in ACH release therefore
| | | | | | | | | |
worsens (not improves) the symptoms of this condition. Reduction in ACh release
| | | | | | | | | | |
by botulinum toxin causes reduction in secretions including saliva (not increase in
| | | | | | | | | | | |
salivation ), causing dry mouth and an increase (not reduction ) in heart rate cut
| | | | | | | | | | | | | | | |
to reduce vagal activity.
| | |
A patient develops urinary retention after an abdominal surgery. Urinary
| | | | | | | | | |
obstruction was ruled out in this patient. Which strategy would be helpful in
| | | | | | | | | | | | |
promoting urination? |
A. Activating nicotinic receptors
| | |
B. Inhibiting the release of acetylcholine
| | | | |
C. Inhibiting cholinesterase enzyme
| | |
, D. Blocking muscarinic receptors - CORRECT ANSWER✔✔-C. Inhibiting
| | | | | | | |
cholinesterase enzyme |
Activation of muscarinic receptors in the detrusor muscle of the urinary bladder
| | | | | | | | | | | |
can promote urination in patients where the tone of detrusor muscle is low.
| | | | | | | | | | | | |
Inhibiting cholinesterase enzyme increases the levels of acetylcholine, and
| | | | | | | | |
acetylcholine can increase the tone of the detrusor muscle. There are no nicotinic
| | | | | | | | | | | |
|receptors in the detrusor muscle; therefore, activation of nicotinic receptors is
| | | | | | | | | | |
not helpful. Inhibiting the release of acetylcholine or blocking muscarinic
| | | | | | | | | |
receptors worsens urinary retention.| | |
Which of the following drugs could theoretically improve asthma symptoms?
| | | | | | | | |
A. Bethanechol
|
B. Pilocarpine
|
C. Pyridostigmine
|
D. Atropine - CORRECT ANSWER✔✔-D. Muscarinic agonists and drugs that
| | | | | | | | | |
increase acetylcholine levels cause constriction of bronchial smooth muscles and
| | | | | | | | | |
could exacerbate asthma symptoms. Bethanechol and pilocarpine are muscarinic
| | | | | | | | |
agonists, and pyrodstigmine is a cholinesterase inhibitor that increases levels of
| | | | | | | | | | |
acetylcholine. Atropine is a muscarinic antagonists and therefore does not
| | | | | | | | | |
exacerbate asthma. theoretically, it should relieve symptoms of asthma (not used
| | | | | | | | | | |
clinically for this purpose).
| | |
If an ophthalmologist wants to dilate the pupils for an eye examination, which
| | | | | | | | | | | | |
drug/class of drugs is theoretically useful?| | | | |
A. Muscarinic receptor activator (agonist)
| | | |
B. Muscarinic receptor inhibitor (antagonist)
| | | |
C. Pilocarpine
|
correct answers
Botulinum toxin blocks the release of acetylcholine from cholinergic nerve
| | | | | | | | | |
terminals. Which is a possible effect of botulinum toxin?
| | | | | | | |
A. Skeletal Muscle paralysis
| | |
B. Improvement of myasthenia gravis symptoms
| | | | |
C. Increased salivation
| |
D. Reduced heart rate - CORRECT ANSWER✔✔-A. Acetylcholine released by
| | | | | | | | | |
cholinergic neurons acts on nicotinic receptors in the skeletal muscle cells to
| | | | | | | | | | | |
cause contraction. Therefore, blockade of ACh release causes skeletal muscle
| | | | | | | | | |
paralysis. Myasthenia gravis is an autoimmune diseases where antibodies are
| | | | | | | | | |
produced against nicotinic receptors. A reduction in ACH release therefore
| | | | | | | | | |
worsens (not improves) the symptoms of this condition. Reduction in ACh release
| | | | | | | | | | |
by botulinum toxin causes reduction in secretions including saliva (not increase in
| | | | | | | | | | | |
salivation ), causing dry mouth and an increase (not reduction ) in heart rate cut
| | | | | | | | | | | | | | | |
to reduce vagal activity.
| | |
A patient develops urinary retention after an abdominal surgery. Urinary
| | | | | | | | | |
obstruction was ruled out in this patient. Which strategy would be helpful in
| | | | | | | | | | | | |
promoting urination? |
A. Activating nicotinic receptors
| | |
B. Inhibiting the release of acetylcholine
| | | | |
C. Inhibiting cholinesterase enzyme
| | |
, D. Blocking muscarinic receptors - CORRECT ANSWER✔✔-C. Inhibiting
| | | | | | | |
cholinesterase enzyme |
Activation of muscarinic receptors in the detrusor muscle of the urinary bladder
| | | | | | | | | | | |
can promote urination in patients where the tone of detrusor muscle is low.
| | | | | | | | | | | | |
Inhibiting cholinesterase enzyme increases the levels of acetylcholine, and
| | | | | | | | |
acetylcholine can increase the tone of the detrusor muscle. There are no nicotinic
| | | | | | | | | | | |
|receptors in the detrusor muscle; therefore, activation of nicotinic receptors is
| | | | | | | | | | |
not helpful. Inhibiting the release of acetylcholine or blocking muscarinic
| | | | | | | | | |
receptors worsens urinary retention.| | |
Which of the following drugs could theoretically improve asthma symptoms?
| | | | | | | | |
A. Bethanechol
|
B. Pilocarpine
|
C. Pyridostigmine
|
D. Atropine - CORRECT ANSWER✔✔-D. Muscarinic agonists and drugs that
| | | | | | | | | |
increase acetylcholine levels cause constriction of bronchial smooth muscles and
| | | | | | | | | |
could exacerbate asthma symptoms. Bethanechol and pilocarpine are muscarinic
| | | | | | | | |
agonists, and pyrodstigmine is a cholinesterase inhibitor that increases levels of
| | | | | | | | | | |
acetylcholine. Atropine is a muscarinic antagonists and therefore does not
| | | | | | | | | |
exacerbate asthma. theoretically, it should relieve symptoms of asthma (not used
| | | | | | | | | | |
clinically for this purpose).
| | |
If an ophthalmologist wants to dilate the pupils for an eye examination, which
| | | | | | | | | | | | |
drug/class of drugs is theoretically useful?| | | | |
A. Muscarinic receptor activator (agonist)
| | | |
B. Muscarinic receptor inhibitor (antagonist)
| | | |
C. Pilocarpine
|